ApoRepair was in Marseille to take part in the “Invest In Biomed” day organized by Eurobiomed. This program, supported by public partners and partly financed by Eurobiomed, is a strong commitment to helping innovative companies succeed.
ApoRepair co-founders Stéphanie Barrère-Lemaire, Éric Thieulin and Joël Nargeot had the opportunity to present their project to a panel of investors. This strategic initiative aims to accelerate the development of their first-in-class therapeutic molecule towards the essential phase of clinical trials.
